| Gene Set | Leading Edge Genes |
|---|
| STEIN ESRRA TARGETS | SLC31A1, TRAK2, ACADSB, ASPH, MGST3, NDRG4, ST3GAL5, AK1, CALU, TRIM2, USP4, ATP5O, WIPI1, PPL, MXD4, MUT, GAS2L1, UGP2, CIAPIN1, NDUFS2, ACYP1, SUCLA2, DECR1, ARL2BP, FZD2, DLAT, VDAC3, PPIC, HTATIP2, NQO2, IMMT, SEPT8, ANXA6, NDUFA9, ACAT1, GFPT1, NDUFS4, PDCD10, CXCL12, TACC1, PLEKHB2, SDHD, PDCL, RABIF, TGFBR2, NNT, RGS19, PFKM, ALDH3A2, PRPS2, ETFDH, TIMM17A, PEA15, NDUFB5, NDUFS1, MDH1, AHCYL1, ATP5G1, CAV2, CDC23, ATP5J, TRAM2, SAMM50, GAS6, EBP, GOT1, ATP5C1, IDH3A, OXA1L, ORC2L, MYO6, B3GNT1, ACAA2, ACADM, NAP1L1, MSH6, PGM1, HEXIM1, ATP1B1, CS, ATP5G3, MIPEP, ATP5L |
| STEIN ESRRA TARGETS UP | NNT, SLC31A1, PFKM, TRAK2, ALDH3A2, ACADSB, MGST3, NDRG4, ST3GAL5, ETFDH, TIMM17A, AK1, NDUFB5, CALU, NDUFS1, TRIM2, USP4, ATP5O, MDH1, AHCYL1, ATP5G1, WIPI1, MUT, GAS2L1, UGP2, ATP5J, CIAPIN1, NDUFS2, ACYP1, UQCRC2, GAS6, SAMM50, SUCLA2, DECR1, EBP, ARL2BP, GOT1, ATP5C1, DLAT, OXA1L, IDH3A, VDAC3, ORC2L, PPIC, HTATIP2, NQO2, ACAA2, ACADM, IMMT, ANXA6, NDUFA9, ACAT1, NDUFS4, PGM1, PDCD10, ATP1B1, PLEKHB2, CS, ATP5G3, MIPEP, SDHD, ATP5L |
| WONG EMBRYONIC STEM CELL CORE | HDAC1, SQLE, SET, BUB1, ELOVL6, GART, CTNNA1, NCBP2, PRPS1, ADSL, TOP2A, SDHC, ADH5, ATP5O, PSMB5, MSH2, GARS, UGDH, ATP5J, FDPS, AMOTL2, BANF1, ZNF22, LSM2, BUB1B, KIF11, LMNB1, MAD2L1, DLAT, CSE1L, RRM1, RPA3, LYPLA1, CCNB2, TTK, NDUFA9, PARP1, KIF23, HADH, POLE2, SLC25A5, BTF3, CCT5, VBP1, NONO, XRCC5, PSME3, SDHD, RCN2 |
| WONG MITOCHONDRIA GENE MODULE | ATP5I, ACADSB, DAP3, MRPL49, NDUFA1, ATP5H, NDUFB5, PDK3, NDUFA6, ATP5O, AUH, ATP5G1, ATP5J, NQO1, GSR, NDUFS2, AK2, COX6C, HAX1, SUCLA2, DECR1, NDUFS5, ATP5C1, VDAC3, SCP2, MRPL40, TFAM, GLUD1, NDUFB3, NDUFA9, ACAT1, SLC25A17, PCCB, NDUFS4, COX4I1, ALDH6A1, ATP1B1, ATP5G3, MIPEP, ATP5L |
| ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UP | SET, GPAA1, MAGOH, RPS25, CETN2, ILF2, HSP90AB1, MGST3, IARS2, CASK, CANX, GPR137B, SDHC, IGBP1, PSMB5, DOCK1, GMPS, WIPI1, PPL, SSR2, CREB3L2, TBCE, CNIH, COPB2, COPA, CTR9, CTCF, ARL2BP, PAPSS1, SEC24D, FARS2, CAP2, PPIC, GNPAT, MRPL40, SMC3, CCT2, NHP2L1, RPL36AL, TAF12, IDH1, GTF2A2, VBP1, SPCS2, PEX19, GMFB, PSME3, RCN2, DYNLL1, AP3S1, ANAPC10, ELOVL6, BMI1, SLC33A1, PEA15, ANKMY2, HTATSF1, NCBP2, NDUFB5, BLVRA, AP3B1, METAP1, WRB, ACP1, PDIA6, TOM1L1, CCT8, ETF1, DDX46, HAX1, SSR1, NUP205, ARL1, TSG101, HPRT1, OXA1L, TMED10, PIR, YIPF1, RPA3, MAPRE1, UBE2N, NDUFB3, PSMB2, SLC9A6, MSH6, PARP1, BTF3, ZMPSTE24, ATP1B1, KIFAP3, IK, SWAP70, NRD1, KDELR2 |
| TARTE PLASMA CELL VS PLASMABLAST DN | MYCBP, RFC3, COPS5, TOP2B, TMPO, PSMA2, CENPA, HSPE1, IQGAP1, DBI, ATP5O, ABCD3, ACTA2, GSPT1, EBNA1BP2, FDPS, SUMO2, KIF2A, CLIC1, KIF11, CDC27, PDLIM1, MTHFD1, SMC1A, CSE1L, ANXA6, YWHAH, NDUFA9, CCT2, CCT5, VBP1, FDFT1, KIF2C, PSMC5, NNT, RB1, PRPS2, UQCRH, CCNB1, GALNT1, GART, TIMM17A, PAK2, RECQL, NDUFS1, TOPBP1, TOP2A, MRPL19, GARS, TCP1, ATP5J, ETF1, UQCRC2, ACVR1, COX6C, CENPE, SSR1, OSTF1, UBE2L3, EBP, LMNB1, MAD2L1, PAICS, ITGB1, CASP6, HPRT1, FOXM1, RRM1, PRKDC, PSMB2, TTK, LBR, KIF23, OAT, ANP32A, SLC39A7 |
| STARK PREFRONTAL CORTEX 22Q11 DELETION DN | MGST3, ASPH, PRPS2, PSMA2, SNX7, SEC22B, ATP5H, CARM1, BLVRA, CYC1, NDUFS1, ADH5, DDX1, PDGFA, YAF2, ATP5J, TCP1, UGP2, ST13, FDPS, NUP88, COPS3, TSPAN31, UQCRC2, PGRMC2, EIF2B4, EIF4G2, PPP2R5C, GLG1, PDCD6, ATP5C1, PPT1, VDAC3, PSMC1, MRPL40, B3GNT1, NDUFA9, CCT2, SRP9, RPL36AL, ACAT2, CCT5, IDH1, SLC25A5, SMYD2, OAT, PRDX3, NONO, CFDP1, SNRPD2, ATP5L |
| REACTOME ELECTRON TRANSPORT CHAIN | NDUFS5, UQCRH, ETFDH, NDUFA1, NDUFB5, NDUFS1, CYC1, SDHC, NDUFA6, NDUFB3, NDUFA9, NDUFS4, COX4I1, NDUFS2, UQCRC2, COX6C, SDHD |
| KEGG PROPANOATE METABOLISM | ACAT1, PCCB, ACAT2, ALDH3A2, MUT, HADHA, ALDH6A1, ALDH7A1, PCCA, SUCLA2, ACADM |
| MOOTHA VOXPHOS | NDUFS5, ATP5I, ATP5C1, UQCRH, NDUFA1, ATP5H, NDUFB5, NDUFS1, CYC1, SDHC, NDUFA6, ATP5O, NDUFB3, NDUFA9, NDUFS4, ATP5G1, COX4I1, ATP5J, NDUFS2, ATP5G3, UQCRC2, COX6C, SDHD, ATP5L |
| NUYTTEN EZH2 TARGETS DN | SET, RDBP, BUB1, ACADSB, TMPO, CETN3, GLT8D1, CENPA, PTK2, CANX, RFC5, SP3, EXOSC8, AUH, EIF4EBP2, NUP88, YWHAQ, ACYP1, HSBP1, CSE1L, GNPAT, SMC3, SRF, YWHAH, CCT2, FBXO21, TPX2, MKRN1, EDEM1, SLC26A2, WIPI2, TBL1X, PJA2, FZD6, PPM1B, PEX19, UMPS, KIF2C, ATP2C1, ALDH3A2, ZWINT, PRPS2, CCNB1, GART, PAK2, TRIAP1, RASSF2, SYPL1, TOPBP1, TOP2A, ARCN1, CENPF, WWTR1, CNOT1, DAZAP2, TRIM37, PPP2R5A, PBXIP1, CYB5B, SPAST, BANF1, CENPE, CDC42, ARL1, NEK9, LSM5, LMNB1, CASP6, ITGB1, ITGA6, CREBL2, HPRT1, FANCG, AZI1, DDHD2, FOXM1, TFAM, RPA3, GALK2, TCF7L2, MTMR4, TTK, WSB2, CCNB2, LBR, KIF23, CDC25C, PPP3CB, FADS1, INHBB, ANP32A, KLHL9, H2AFV, HDAC2, IK, KCNK1 |
| REACTOME CELL CYCLE MITOTIC | PSMC5, PSMD7, CDC16, ANAPC10, CETN2, BUB1, ZWINT, PSMA2, RAD21, CCNB1, CENPA, PSMB1, CKAP5, PSMA4, STAG1, RFC5, CENPF, PSMB5, CDC23, CDK7, MCM6, PPP2R1B, CDK2, PPP2R5C, PSMD5, BUB1B, KIF2A, CDC27, MAD2L1, UBE2D1, ORC2L, PPP2CA, HSP90AA1, AZI1, SMC1A, PSMD1, PSMC1, PSMB7, RPA3, MAPRE1, SMC3, PSMF1, PSMB2, CCNB2, KIF23, CDC25C, POLE2, DCTN2, KIF2C, DYNLL1 |
| BUYTAERT PHOTODYNAMIC THERAPY STRESS DN | MYCBP, GPAA1, BUB1, FPGT, AK1, RHOBTB3, PARP2, MECP2, CDKN2C, VCL, AMOTL2, LSM2, HRSP12, XPA, SYNPO, UBTF, MAPK14, AMD1, PPIC, MRPL40, NHP2L1, ID1, HADH, SLC26A2, ANAPC13, TBL1X, ARF3, FANCL, TARDBP, PSME3, PON2, RABIF, TGFBR2, SEPHS1, ELOVL6, SUB1, PEX11B, ICMT, TOP2A, ZDHHC3, LANCL1, EBAG9, CAV2, ATP5G1, ITGB3, AK2, IRS1, TRAM2, PGRMC2, ZNF22, OSTF1, EBP, TEX261, LMNB1, ZMYM3, B3GNT1, CTDSPL, PTDSS1, UBQLN2, HEXIM1, POLE2, PMS1, INHBB, EHMT2 |
| WELCSH BRCA1 TARGETS 1 UP | HDAC1, SEC23A, KIF2A, KIF11, ALDH7A1, PRKAR1A, SMC1A, PPIC, NDUFS1, IQGAP1, ALCAM, SDHC, ID4, CALM2, ABCD3, TRAM1, WRB, TAF12, RDX, IDH1, JAK1, CXADR, ARPC1A, KIFAP3, ANXA4, VAMP3, PPP2R5C, KDELR2, KIF2C, TM9SF1 |
| BLUM RESPONSE TO SALIRASIB DN | HDAC1, MYCBP, UPK1B, DPYSL3, TOP2B, ZWINT, TMPO, GALNT1, STMN1, CENPA, PRPS1, RFC5, TOP2A, CENPF, WWTR1, ABCD3, MSH2, CBFB, CDKN2C, CDK2AP1, MCM6, YWHAQ, IRS1, CDK2, EBP, BUB1B, KIF11, MAD2L1, FZD2, VDAC3, HSP90AA1, CSE1L, SMC1A, RRM1, MAPRE2, RPA3, B3GNT1, PLS3, PIAS3, CCNB2, TTK, MSH6, SRP9, ID1, PARP1, TPX2, KIF23, CDC25C, POLE2, UBE2E3, ATP5G3, PRDX3, H2AFV, GPSM2, MIPEP, KIF2C |
| WEST ADRENOCORTICAL TUMOR UP | SQLE, HDAC1, SC5DL, NNT, HMGCR, POLE3, ELOVL6, ZWINT, TMPO, CCNB1, RPN2, ANKMY2, RHOBTB3, SPTLC1, ICMT, RFC5, TOP2A, CENPF, SCD, CD164, CAND1, CDC23, TMEM106C, TCP1, FDPS, MELK, TNPO1, ANXA4, EBP, MED8, BUB1B, FOXM1, PIR, PSMB7, VPS41, MAPRE1, ACTR2, MLF1, SC4MOL, WSB2, ACAT2, TPX2, CDC25C, TMED9, ZMPSTE24, PLEKHB2, DCTN2, KIF2C |
| SASAKI ADULT T CELL LEUKEMIA | BUB1B, CAV1, HDAC1, ATP2C1, AP3S1, MYCBP, KIF11, ZWINT, CCNB1, SMARCA2, FOXM1, ICMT, FHL2, WWTR1, ATP6V1A, PSMB2, ANXA6, CCNB2, PARP1, TPX2, PLD1, PDCD10, IDH1, SGCE, ATP1B1, FZD6, ATP5G3, LSM2, KIF2C |
| PAL PRMT5 TARGETS UP | SET, NNT, PPP1R7, CETN2, TMPO, CETN3, STMN1, SLBP, FKBP4, CARM1, NCBP2, RFC5, PSMB5, PKD2, NUP88, COPS3, EIF4G2, LSM2, ARL2BP, KIF11, NDN, RRM1, ABCG2, PSIP1, FMR1, TTK, CCNB2, CDC25C, KIF23, CXCL12, POLE2, SPCS2, UBE2E3, HAT1, NONO, H2AFV, CFDP1, TARDBP, EHMT2, RCN2, ERH |
| BENPORATH PROLIFERATION | MAD2L1, ILF2, GART, STMN1, CENPA, CSE1L, NDUFB5, TOP2A, CENPF, TTK, CCNB2, PRPF18, LBR, GARS, MSH2, PARP1, RDX, PDCD10, SLC25A5, HDAC2, H2AFV, GPSM2, KDELR2 |
| MARKEY RB1 ACUTE LOF DN | CAV1, SET, KIF2A, KIF11, MAD2L1, TMPO, CCNB1, STMN1, CENPA, CSE1L, EI24, ADSL, SMC3, RFC5, WWTR1, PSIP1, CCNB2, DSTN, PARP1, TRIM37, CDC25C, KIF23, TMEM106C, H2AFV, HDAC2, TARDBP, CDK2, IL1R1 |
| SANA RESPONSE TO IFNG DN | HDGF, ILF2, HSP90AB1, MGST3, PRSS23, TIMM17A, CSE1L, RAN, EI24, TPX2, CCT5, NQO1, SMYD2, SSR2, CTNNAL1, OAT, YWHAQ, HDAC2, SNRPD2, DAB2, EIF4G2, PON2, KDELR2 |
| REACTOME CELL CYCLE CHECKPOINTS | PSMD5, BUB1B, PSMC5, PSMD7, CDC16, ANAPC10, CDC27, MAD2L1, UBE2D1, PSMA2, ORC2L, CCNB1, PSMB1, PSMC1, PSMA4, PSMD1, PSMB7, RPA3, RFC5, PSMF1, PSMB2, CCNB2, PSMB5, CDC23, CDC25C, MCM6 |
| REACTOME DNA REPLICATION PRE INITIATION | PSMD5, PSMC5, PSMD7, PSMA2, ORC2L, PSMB1, PSMD1, PSMC1, PSMA4, PSMB7, RPA3, PSMF1, PSMB2, PSMB5, POLE2, MCM6 |
| LINDGREN BLADDER CANCER CLUSTER 3 UP | DYNLT3, ZWINT, TMPO, PRPS2, CCNB1, STMN1, CENPA, RASSF2, TOP2A, CENPF, MSH2, TOM1L1, CDKN2C, TMEM106C, ZNF148, MCM6, YWHAQ, MELK, AK2, CDK2, ANXA4, COPB2, EBP, KIF11, MAD2L1, GNPAT, AKAP12, ALDH9A1, MAPRE1, RPA3, CCNB2, MLF1, NDUFA9, INSIG1, PTPLB, KIF23, H2AFV, KIFAP3, KIF2C |
| KEGG CELL CYCLE | BUB1B, HDAC1, CDC16, ANAPC10, CDC27, MAD2L1, BUB1, ORC2L, CCNB1, SMC1A, STAG1, SMC3, PRKDC, YWHAH, TTK, CCNB2, CDKN2C, CDC23, CDC25C, CDK7, ANAPC13, MCM6, YWHAQ, HDAC2, CDK2 |
| NCI SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | PSMB2, PSMC5, PSMD5, PSMB5, PSMD7, PSMA2, PSMB1, SKP1A, PSMD1, PSMC1, PSMA4, PSMB7, PSMF1 |
| CORUM PA700-20S-PA28 COMPLEX | PSMB2, PSMC5, PSMD5, PSMB5, PSMD7, PSMA2, PSMB1, PSMD1, PSMC1, PSMA4, PSMB7 |
| FUJII YBX1 TARGETS DN | BUB1B, LMNB1, KIF11, MAD2L1, ZWINT, FOXM1, NCBP2, EI24, CALU, RFC5, YWHAH, CDC23, CDC25C, HADH, POLE2, MCM6, CASP2, MELK, CDK2, SSR1 |
| CHIANG LIVER CANCER SUBCLASS UNANNOTATED DN | YAP1, RFC3, POLE3, ILF2, DAD1, PSMA2, RAN, SNX7, SYPL1, PRPS1, RFC5, DBI, PDIA6, MSH2, CTNNAL1, ARPC1A, COPS3, RNASEH2A, VAMP3, CNN3, NUP205, MAGED1, LSM2, COPA, RHOA, MAD2L1, VDAC3, DPM1, SNX2, MAPRE1, ATP1A1, RPA3, CCNB2, CCT2, TPX2, POLE2, SLC25A5, VBP1, UBE2E3, NONO, HAT1, XRCC5, SNRPD2, RCN2 |
| NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION1 | PSMB2, PSMC5, PSMD5, PSMB5, PSMD7, PSMA2, PSMB1, PSMD1, PSMC1, PSMA4, PSMB7, PSMF1 |
| SOTIRIOU BREAST CANCER GRADE 1 VS 3 UP | BUB1B, LMNB1, KIF11, MAD2L1, ZWINT, CCNB1, STMN1, CENPA, FOXM1, TOP2A, CCNB2, TTK, TPX2, CCT5, MCM6, H2AFV, MELK, CDK2, KIF2C |
| NCI CITRIC ACID CYCLE TCA CYCLE | CS, SDHD, SUCLA2, SDHC |
| CORUM 20S PROTEASOME | PSMA1, PSMB2, PSMA4, PSMB5, PSMB7, PSMB6, PSMB1 |
| BIOCARTA PROTEASOME PATHWAY | PSMB2, PSMB5, PSMA2, RPN2, PSMB1, PSMA4, PSMB7, UBE3A, UBE2A |
| MISSIAGLIA REGULATED BY METHYLATION DN | CAV1, BUB1B, LMNB1, PAICS, ZWINT, STMN1, FOXM1, PIR, RRM1, RPA3, RFC5, PSIP1, MSH6, LBR, ACAT2, CDKN2C, KIF23, CDC25C, EBP |
| LEE EARLY T LYMPHOCYTE UP | ADA, BUB1B, CCNB2, TTK, KIF11, SCRN1, CCNB1, CENPA, MELK, KIF2C, PALLD |
| KANG DOXORUBICIN RESISTANCE UP | BUB1B, CDKN3, LMNB1, MAD2L1, TPX2, ZWINT, CDC6, NQO1, CENPA, FOXM1, RRM1, HMMR, TOP2A, BIRC5 |
| RHODES UNDIFFERENTIATED CANCER | MAD2L1, GARS, ILF2, KIF23, CCNB1, DPM1, CENPA, FOXM1, MCM6, PSMB7, MELK, GAS6, RPA3, TOP2A, KIF2C |
| CHIANG LIVER CANCER SUBCLASS PROLIFERATION UP | BUB1B, LMNB1, KIF11, MAD2L1, MMD, ZWINT, PLP2, CCNB1, FOXM1, TOP2A, CD24, TTK, CCNB2, TPX2, KIF23, WASF1, GPD1L, HDAC2, KIF2C |
| BIOCARTA CDC42RAC PATHWAY | ARPC1A, ARPC5, ARPC2, RHOA, PIK3R1, CDC42, ACTR2 |
| CROONQUIST NRAS SIGNALING DN | BUB1B, CCNB2, KIF11, TPX2, ZWINT, CDC25C, CCNB1, CENPA, CSE1L, FOXM1, TOP2A, KIF2C |
| FAELT B CLL WITH VH REARRANGEMENTS DN | PFN2, GTF3A, FKBP1B, TMED10, TSPYL4, YWHAQ, SEP15, MRPL40, XBP1, PRPS1 |
| NCI AR PATHWAY | XRCC5, ZNF318, PIAS3, CARM1, FKBP4, UBE3A, FHL2, CTDSP2 |
| ROSTY CERVICAL CANCER PROLIFERATION CLUSTER | BUB1B, LMNB1, KIF11, MAD2L1, ZWINT, TMPO, CCNB1, CENPA, FOXM1, RPA3, TOP2A, CENPF, TTK, CCNB2, TPX2, KIF23, MELK, KIF2C, EBP |
| CROMER METASTASIS UP | CD164, PARP1, BMI1, PPT1, GANAB, SMC1A, CDH11, TMEM123, SH3BP5, TBCE, KIFAP3, CNN3, SH3BGRL, DEK |
| CORUM ANTI-HDAC2 COMPLEX | |
| CORUM KU ANTIGEN-YY1-ALPHAMYHC PROMOTER COMPLEX | |
| MARTINEZ RESPONSE TO TRABECTEDIN | |
| PUJANA BRCA1 PCC NETWORK | |
| SCIAN CELL CYCLE TARGETS OF TP53 AND TP73 DN | |
| BOYAULT LIVER CANCER SUBCLASS G123 UP | |
| ROME INSULIN TARGETS IN MUSCLE UP | |
| PUJANA BRCA2 PCC NETWORK | |
| KUMAMOTO RESPONSE TO NUTLIN 3A DN | |
| GINESTIER BREAST CANCER ZNF217 AMPLIFIED UP | |
| HORIUCHI WTAP TARGETS DN | |
| NCI REPAIR SYNTHESIS FOR GAP FILLING BY DNA POLYMERASE IN TC NER | |
| FRASOR RESPONSE TO SERM OR FULVESTRANT DN | |
| LINDGREN BLADDER CANCER WITH LOH IN CHR9Q | |
| ZHAN VARIABLE EARLY DIFFERENTIATION GENES DN | |
| REN BOUND BY E2F | |
| PUJANA BREAST CANCER LIT INT NETWORK | |
| KEGG MISMATCH REPAIR | |
| CORUM PA28GAMMA-20S PROTEASOME | |
| HUMMEL BURKITTS LYMPHOMA UP | |
| PUIFFE INVASION INHIBITED BY ASCITES UP | |
| NCI MITOTIC METAPHASE ANAPHASE TRANSITION | |
| REACTOME APCDC20 MEDIATED DEGRADATION OF CYCLIN B | |
| SENESE HDAC3 TARGETS DN | |
| REACTOME SYNTHESIS OF DNA | |
| SHEDDEN LUNG CANCER POOR SURVIVAL A6 | |
| MEINHOLD OVARIAN CANCER LOW GRADE DN | |
| GINESTIER BREAST CANCER 20Q13 AMPLIFICATION UP | |
| MORI EMU MYC LYMPHOMA BY ONSET TIME UP | |
| KEGG PEROXISOME | |
| SEIDEN ONCOGENESIS BY MET | |
| FARMER BREAST CANCER CLUSTER 6 | |
| WAKASUGI HAVE ZNF143 BINDING SITES | |
| WANG RESPONSE TO ANDROGEN UP | |
| KAPOSI LIVER CANCER POOR SURVIVAL UP | |
| REACTOME MITOTIC PROMETAPHASE | |
| BIOCARTA ACTINY PATHWAY | |
| KEGG PROTEIN EXPORT | |
| LIANG HEMATOPOIESIS STEM CELL NUMBER LARGE VS TINY UP | |
| LASTOWSKA NEUROBLASTOMA COPY NUMBER DN | |
| CORUM KU-ORC COMPLEX | |
| CORUM H2AX COMPLEX ISOLATED FROM CELLS WITHOUT IR EXPOSURE | |
| WOOD EBV EBNA1 TARGETS DN | |
| HOSHIDA LIVER CANCER SUBCLASS S2 | |
| BENPORATH NANOG TARGETS | |
| GRADE COLON AND RECTAL CANCER UP | |
| FINETTI BREAST CANCER BASAL VS LUMINAL | |
| NOUZOVA TRETINOIN AND H4 ACETYLATION | |
| GOLDRATH HOMEOSTATIC PROLIFERATION | |
| GENTILE UV RESPONSE CLUSTER D6 | |
| NCI MRNA SPLICING MAJOR PATHWAY | |
| ZHONG RESPONSE TO AZACITIDINE AND TSA DN | |
| REACTOME G1 S TRANSITION | |
| BLALOCK ALZHEIMERS DISEASE DN | |
| FOURNIER ACINAR DEVELOPMENT LATE 2 | |
| MOHANKUMAR TLX1 TARGETS UP | |
| NCI APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | |
| KIM WT1 TARGETS DN | |
| NCI VIF MEDIATED DEGRADATION OF APOBEC3G | |
| CORUM CSA-POLIIA COMPLEX | |
| LIU CMYB TARGETS DN | |
| NCI DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | |
| SCHLOSSER MYC TARGETS AND SERUM RESPONSE DN | |
| DODD NASOPHARYNGEAL CARCINOMA DN | |
| KEGG NUCLEOTIDE EXCISION REPAIR | |
| BENPORATH MYC MAX TARGETS | |
| SEIDEN MET SIGNALING | |
| NCI MITOCHONDRIAL FATTY ACID BETA OXIDATION OF UNSATURATED FATTY ACIDS | |
| RODRIGUES THYROID CARCINOMA ANAPLASTIC DN | |
| BHATTACHARYA EMBRYONIC STEM CELL | |
| ALONSO METASTASIS UP | |
| NCI PHOSPHORYLATION OF THE APC C | |
| WAESCH ANAPHASE PROMOTING COMPLEX | |
| MOLENAAR TARGETS OF CCND1 AND CDK4 DN | |
| NCI APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | |
| HAHTOLA MYCOSIS FUNGOIDES CD4 DN | |
| LI WILMS TUMOR VS FETAL KIDNEY 1 UP | |
| ONKEN UVEAL MELANOMA UP | |
| CORUM PA28-20S PROTEASOME | |
| RODWELL AGING KIDNEY NO BLOOD DN | |
| NCI MITOTIC PROMETAPHASE | BUB1B, KIF2A, ZWINT, CENPA, SMC1A, CKAP5, STAG1, SMC3, MAPRE1, KIF2C |
| NCI CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | |
| REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | ATP5O, ATP5H, ATP5I, ATP5C1, ATP5G1, ATP5J, ATP5L |
| MANN RESPONSE TO AMIFOSTINE DN | |
| CORUM MSH2/6-BLM-P53-RAD51 COMPLEX | |
| CAIRO HEPATOBLASTOMA CLASSES UP | |
| BIOCARTA SALMONELLA PATHWAY | |
| NCI SMAD2 3PATHWAY | |
| WANG LMO4 TARGETS DN | |
| DE YY1 TARGETS DN | |
| WATANABE RECTAL CANCER RADIOTHERAPY RESPONSIVE UP | |
| CORUM UBIQUILIN-PROTEASOME COMPLEX | |
| SCIBETTA KDM5B TARGETS DN | |
| BIOCARTA RB PATHWAY | |
| REACTOME TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL | |
| VANTVEER BREAST CANCER ESR1 UP | |
| CHEMNITZ RESPONSE TO PROSTAGLANDIN E2 UP | |
| NAKAMURA TUMOR ZONE PERIPHERAL VS CENTRAL UP | |
| PUJANA XPRSS INT NETWORK | |
| BENPORATH CYCLING GENES | |
| RAMALHO STEMNESS UP | |
| CHOW RASSF1 TARGETS UP | |
| CORUM DNA SYNTHESOME COMPLEX 17 SUBUNITS | |
| KEGG PARKINSONS DISEASE | |
| KEGG OOCYTE MEIOSIS | |
| NCI APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | |
| NCI APC CDC20 MEDIATED DEGRADATION OF NEK2A | |
| SAKAI TUMOR INFILTRATING MONOCYTES DN | |
| SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN DN | |
| CORUM 26S PROTEASOME | |
| WANG CLIM2 TARGETS DN | |
| GOTTWEIN TARGETS OF KSHV MIR K12 11 | |
| YU MYC TARGETS UP | |
| CROONQUIST IL6 DEPRIVATION DN | |
| BARRIER COLON CANCER RECURRENCE UP | |
| FINETTI BREAST CANCER KINOME RED | |
| RHODES CANCER META SIGNATURE | |
| VANTVEER BREAST CANCER METASTASIS DN | |
| NCI FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | |
| GALE APL WITH FLT3 MUTATED UP | |
| KEGG FATTY ACID METABOLISM | |
| GRAHAM CML DIVIDING VS NORMAL QUIESCENT UP | |
| DANG BOUND BY MYC | |
| NCI AURORA B PATHWAY | |
| THEILGAARD NEUTROPHIL AT SKIN WOUND DN | |
| NCI PLK1 PATHWAY | |
| BLALOCK ALZHEIMERS DISEASE INCIPIENT DN | |
| GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING DN | |
| OUELLET OVARIAN CANCER INVASIVE VS LMP UP | |
| REACTOME PEROXISOMAL LIPID METABOLISM | |
| CORUM F1F0-ATP SYNTHASE EC 3.6.3.14 MITOCHONDRIAL | ATP5O, ATP5H, ATP5I, ATP5C1, ATP5G1, ATP5J, ATP5L |
| CHOI ATL CHRONIC VS ACUTE DN | |
| MOREAUX B LYMPHOCYTE MATURATION BY TACI DN | |
| NCI ORC1 REMOVAL FROM CHROMATIN | |
| CORUM CTBP CORE COMPLEX | |
| CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA DN | |
| KEGG UBIQUITIN MEDIATED PROTEOLYSIS | |
| RODRIGUES THYROID CARCINOMA POORLY DIFFERENTIATED UP | |
| KOBAYASHI EGFR SIGNALING 24HR DN | |
| REACTOME CHOLESTEROL BIOSYNTHESIS | |
| BOYAULT LIVER CANCER SUBCLASS G23 UP | |
| CORUM DNA SYNTHESOME COMPLEX 13 SUBUNITS | |
| REACTOME HOST INTERACTIONS OF HIV FACTORS | |
| CREIGHTON ENDOCRINE THERAPY RESISTANCE 1 | |
| VALK AML CLUSTER 15 | |
| CORUM EXOSOME | |
| LOPEZ MESOTHELIOMA SURVIVAL UP | |
| REACTOME CITRIC ACID CYCLE | |
| NCI VPU MEDIATED DEGRADATION OF CD4 | |
| LIN MELANOMA COPY NUMBER UP | |
| YANG BREAST CANCER ESR1 LASER DN | |
| GENTILE RESPONSE CLUSTER D3 | |
| NCI P38 MK2PATHWAY | |
| LU AGING BRAIN DN | |
| MORI IMMATURE B LYMPHOCYTE DN | |
| SAKAI CHRONIC HEPATITIS VS LIVER CANCER UP | |
| YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 13 | |
| KEGG OXIDATIVE PHOSPHORYLATION | |
| CAFFAREL RESPONSE TO THC 24HR 5 UP | |
| WANG LMO4 TARGETS UP | |
| GARY CD5 TARGETS DN | |
| NCI INSULIN SYNTHESIS AND SECRETION | TRAM1, SRP9, TRAM2, SRP72, RPN2, SSR2, SPCS2 |
| HAMAI APOPTOSIS VIA TRAIL UP | |
| SESTO RESPONSE TO UV C8 | |
| CORUM ANAPHASE-PROMOTING COMPLEX | |
| GENTILE UV RESPONSE CLUSTER D8 | |
| MORI LARGE PRE BII LYMPHOCYTE UP | |
| PUJANA BRCA CENTERED NETWORK | |
| NCI INACTIVATION OF APC C VIA DIRECT INHIBITION OF THE APC C COMPLEX | BUB1B, CDC16, ANAPC10, CDC27, MAD2L1, UBE2D1, CDC23 |
| NUYTTEN NIPP1 TARGETS DN | |
| JI RESPONSE TO FSH DN | |
| KAYO CALORIE RESTRICTION MUSCLE DN | |
| WENDT COHESIN TARGETS UP | |
| ACEVEDO LIVER CANCER UP | |
| REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | |
| REACTOME PHOSPHORYLATION OF THE APC | |
| SONG TARGETS OF IE86 CMV PROTEIN | |
| WAMUNYOKOLI OVARIAN CANCER LMP DN | |
| REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | |
| JAERVINEN AMPLIFIED IN LARYNGEAL CANCER | |
| JIANG HYPOXIA CANCER | |
| FLECHNER BIOPSY KIDNEY TRANSPLANT REJECTED VS OK DN | |
| MMS MOUSE LYMPH HIGH 4HRS UP | |
| BROWNE HCMV INFECTION 20HR DN | |
| REACTOME CONVERSION FROM APC CDC20 TO APC CDH1 IN LATE ANAPHASE | |
| ZHAN MULTIPLE MYELOMA SUBGROUPS | |
| MILI PSEUDOPODIA CHEMOTAXIS UP | |
| BASSO B LYMPHOCYTE NETWORK | |
| ODONNELL TARGETS OF MYC AND TFRC DN | |
| ZHAN MULTIPLE MYELOMA PR UP | |
| DAZARD RESPONSE TO UV SCC UP | |
| KAUFFMANN MELANOMA RELAPSE UP | |
| HOFFMANN LARGE TO SMALL PRE BII LYMPHOCYTE UP | |
| CORUM CSA COMPLEX | |
| NAKAMURA CANCER MICROENVIRONMENT DN | |
| FAELT B CLL WITH VH3 21 DN | |
| CORUM BRM-SIN3A COMPLEX | |
| BIOCARTA MEF2D PATHWAY | |
| REACTOME INACTIVATION OF APC VIA DIRECT INHIBITION OF THE APCOMPLEX | |
| LAIHO COLORECTAL CANCER SERRATED UP | |
| REACTOME CYCLIN A1 ASSOCIATED EVENTS DURING G2 M TRANSITION | |
| MARTINEZ RESPONSE TO TRABECTEDIN DN | |
| KAUFFMANN DNA REPAIR GENES | |
| LOPES METHYLATED IN COLON CANCER DN | |
| NCI REGULATION OF APC C ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE | |
| GEORGES TARGETS OF MIR192 AND MIR215 | |
| GOLDRATH ANTIGEN RESPONSE | |
| ONKEN UVEAL MELANOMA DN | |
| NCI TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL | |
| FERRANDO T ALL WITH MLL ENL FUSION DN | |
| DING LUNG CANCER EXPRESSION BY COPY NUMBER | |
| STEIN ESRRA TARGETS DN | |
| LEE LIVER CANCER SURVIVAL DN | |
| KAYO AGING MUSCLE DN | |
| MUELLER PLURINET | |
| MANALO HYPOXIA DN | |
| RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY UP | |
| HU ANGIOGENESIS DN | |
| RICKMAN METASTASIS UP | |
| KAAB FAILED HEART ATRIUM DN | |
| NCI CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | |
| LINDGREN BLADDER CANCER CLUSTER 1 UP | |
| SHAFFER IRF4 TARGETS IN ACTIVATED B LYMPHOCYTE | |
| FERREIRA EWINGS SARCOMA UNSTABLE VS STABLE UP | |
| KINSEY TARGETS OF EWSR1 FLII FUSION UP | |
| REACTOME S PHASE | |
| CAFFAREL RESPONSE TO THC 24HR 5 DN | |
| CHANG CYCLING GENES | CCNB2, LMNB1, ILF2, KIF23, CDC25C, CENPA, FOXM1, MELK |
| MOREAUX MULTIPLE MYELOMA BY TACI DN | |
| OUELLET CULTURED OVARIAN CANCER INVASIVE VS LMP UP | |
| CORUM SNF2H-COHESIN-NURD COMPLEX | |
| FARMER BREAST CANCER CLUSTER 2 | |
| FLECHNER PBL KIDNEY TRANSPLANT OK VS DONOR UP | |
| FLECHNER PBL KIDNEY TRANSPLANT REJECTED VS OK UP | |
| AMUNDSON GAMMA RADIATION RESPONSE | CCNB2, TTK, LBR, MAD2L1, CDKN2C, KIF23, CDC25C, CCNB1, CENPA |
| KEGG PROGESTERONE MEDIATED OOCYTE MATURATION | |
| REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | |
| TIEN INTESTINE PROBIOTICS 6HR DN | |